166 related articles for article (PubMed ID: 16107596)
1. Parenteral nutrition-associated cholestasis in neonates: multivariate analysis of the potential protective effect of taurine.
Spencer AU; Yu S; Tracy TF; Aouthmany MM; Llanos A; Brown MB; Brown M; Shulman RJ; Hirschl RB; Derusso PA; Cox J; Dahlgren J; Strouse PJ; Groner JI; Teitelbaum DH
JPEN J Parenter Enteral Nutr; 2005; 29(5):337-43; discussion 343-4. PubMed ID: 16107596
[TBL] [Abstract][Full Text] [Related]
2. [Factors derived from parenteral nutrition associated with cholestasis in 612 neonates].
Tang QY; Wang Y; Feng Y; Tao YX; Wu J; Cai W
Zhonghua Er Ke Za Zhi; 2007 Nov; 45(11):838-42. PubMed ID: 18282416
[TBL] [Abstract][Full Text] [Related]
3. Effects of protein/nonprotein caloric intake on parenteral nutrition associated cholestasis in premature infants weighing 600-1000 grams.
Blau J; Sridhar S; Mathieson S; Chawla A
JPEN J Parenter Enteral Nutr; 2007; 31(6):487-90. PubMed ID: 17947604
[TBL] [Abstract][Full Text] [Related]
4. Randomized controlled trial of early parenteral nutrition cycling to prevent cholestasis in very low birth weight infants.
Salvador A; Janeczko M; Porat R; Sekhon R; Moewes A; Schutzman D
J Pediatr; 2012 Aug; 161(2):229-33.e1. PubMed ID: 22424948
[TBL] [Abstract][Full Text] [Related]
5. A double-blind randomised controlled trial of fish oil-based versus soy-based lipid preparations in the treatment of infants with parenteral nutrition-associated cholestasis.
Lam HS; Tam YH; Poon TC; Cheung HM; Yu X; Chan BP; Lee KH; Lee BS; Ng PC
Neonatology; 2014; 105(4):290-6. PubMed ID: 24576844
[TBL] [Abstract][Full Text] [Related]
6. Use of cholecystokinin-octapeptide for the prevention of parenteral nutrition-associated cholestasis.
Teitelbaum DH; Tracy TF; Aouthmany MM; Llanos A; Brown MB; Yu S; Brown MR; Shulman RJ; Hirschl RB; Derusso PA; Cox J; Dahlgren J; Groner JI; Strouse PJ
Pediatrics; 2005 May; 115(5):1332-40. PubMed ID: 15867044
[TBL] [Abstract][Full Text] [Related]
7. Increased incidence of parenteral nutrition-associated cholestasis with aminosyn PF compared to trophamine.
Wright K; Ernst KD; Gaylord MS; Dawson JP; Burnette TM
J Perinatol; 2003 Sep; 23(6):444-50. PubMed ID: 13679929
[TBL] [Abstract][Full Text] [Related]
8. Incidence, prevention, and treatment of parenteral nutrition-associated cholestasis and intestinal failure-associated liver disease in infants and children: a systematic review.
Lauriti G; Zani A; Aufieri R; Cananzi M; Chiesa PL; Eaton S; Pierro A
JPEN J Parenter Enteral Nutr; 2014 Jan; 38(1):70-85. PubMed ID: 23894170
[TBL] [Abstract][Full Text] [Related]
9. Parenteral nutrition-associated conjugated hyperbilirubinemia in hospitalized infants.
Klein CJ; Revenis M; Kusenda C; Scavo L
J Am Diet Assoc; 2010 Nov; 110(11):1684-95. PubMed ID: 21034882
[TBL] [Abstract][Full Text] [Related]
10. Cumulative amount of intravenous lipid intake and parenteral nutrition-associated cholestasis in neonates with gastrointestinal surgical disorders.
Nayrouz MM; Amin SB
Am J Perinatol; 2014 May; 31(5):419-24. PubMed ID: 24000109
[TBL] [Abstract][Full Text] [Related]
11. Parenteral nutrition-associated cholestasis in premature babies: risk factors and predictors.
Hsieh MH; Pai W; Tseng HI; Yang SN; Lu CC; Chen HL
Pediatr Neonatol; 2009 Oct; 50(5):202-7. PubMed ID: 19856863
[TBL] [Abstract][Full Text] [Related]
12. [Risk factors for parenteral nutrition-associated cholestasis in neonates].
Feng Q
Zhongguo Dang Dai Er Ke Za Zhi; 2014 Jul; 16(7):670-3. PubMed ID: 25008870
[TBL] [Abstract][Full Text] [Related]
13. [Clinical features of parenteral nutrition associated cholestasis in preterm infants].
Wang CH; Shi LP; Wu XJ; Chen Z; Luo F
Zhonghua Er Ke Za Zhi; 2011 Mar; 49(3):199-202. PubMed ID: 21575370
[TBL] [Abstract][Full Text] [Related]
14. [Risk factors for parenteral nutrition-associated cholestasis in preterm infants].
Li YH; Wang XL
Zhongguo Dang Dai Er Ke Za Zhi; 2013 Apr; 15(4):254-8. PubMed ID: 23607945
[TBL] [Abstract][Full Text] [Related]
15. Male sex predisposes the newborn surgical patient to parenteral nutrition-associated cholestasis and to sepsis.
Albers MJ; de Gast-Bakker DA; van Dam NA; Madern GC; Tibboel D
Arch Surg; 2002 Jul; 137(7):789-93. PubMed ID: 12093333
[TBL] [Abstract][Full Text] [Related]
16. Parenteral nutrition-associated cholestasis in neonates: the role of aluminum.
Arnold CJ; Miller GG; Zello GA
Nutr Rev; 2003 Sep; 61(9):306-10. PubMed ID: 14552065
[TBL] [Abstract][Full Text] [Related]
17. Parenteral nutrition associated cholestasis is earlier, more prolonged and severe in small for gestational age compared with appropriate for gestational age very low birth weight infants.
Lee SM; Namgung R; Park MS; Eun HS; Kim NH; Park KI; Lee C
Yonsei Med J; 2013 Jul; 54(4):839-44. PubMed ID: 23709416
[TBL] [Abstract][Full Text] [Related]
18. Could lipid infusion be a risk for parenteral nutrition-associated cholestasis in low birth weight neonates?
Shin JI; Namgung R; Park MS; Lee C
Eur J Pediatr; 2008 Feb; 167(2):197-202. PubMed ID: 17436017
[TBL] [Abstract][Full Text] [Related]
19. Percutaneous cholangiography for the treatment of parenteral nutrition-associated cholestasis in surgical neonates: preliminary experience.
Wales PW; Brindle M; Sauer CJ; Patel S; de Silva N; Chait P
J Pediatr Surg; 2007 Nov; 42(11):1913-8. PubMed ID: 18022446
[TBL] [Abstract][Full Text] [Related]
20. High-dose oral erythromycin decreased the incidence of parenteral nutrition-associated cholestasis in preterm infants.
Ng PC; Lee CH; Wong SP; Lam HS; Liu FY; So KW; Lee CY; Fok TF
Gastroenterology; 2007 May; 132(5):1726-39. PubMed ID: 17484870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
